A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions.

Autor: Donzelli, Sara1 (AUTHOR), Cioce, Mario2,3 (AUTHOR), Sacconi, Andrea4 (AUTHOR), Zanconato, Francesca5 (AUTHOR), Daralioti, Theodora6 (AUTHOR), Goeman, Frauke7 (AUTHOR), Orlandi, Giulia8 (AUTHOR), Di Martino, Simona9 (AUTHOR), Fazio, Vito Michele2,3,10 (AUTHOR), Alessandrini, Gabriele11 (AUTHOR), Telera, Stefano12 (AUTHOR), Carosi, Mariantonia6 (AUTHOR), Ciliberto, Gennaro13 (AUTHOR), Botti, Claudio14 (AUTHOR), Strano, Sabrina7 (AUTHOR), Piccolo, Stefano5,15 (AUTHOR), Blandino, Giovanni1 (AUTHOR) giovanni.blandino@ifo.it
Zdroj: Molecular Cancer. 7/22/2022, Vol. 21 Issue 1, p1-7. 7p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje